Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026)

Nyxoah (NYXH) recorded quarterly Income from Continuing Operations of 18209777.84 in Q1 2026, down 99.93% quarter-over-quarter from 26328336215.46 in Q4 2025, and down 22.23% on a YoY basis from 23413895.74 in Q1 2025.

Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026) Analysis & Trends

Nyxoah's Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 18209777.84 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations fell 22.23% year-over-year to 18209777.84; the TTM figure through Mar 2026 stood at 26295629039.77 (up 263.59% YoY), while the FY2025 annual figure was 104862860.02, down 65.66% from the prior year.
  • Income from Continuing Operations was 18209777.84 for Q1 2026 at Nyxoah, down from 26328336215.46 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 26328336215.46 in Q4 2025 to a low of 16102664085.05 in Q4 2024.
  • Historically, Income from Continuing Operations has averaged 99687652.97 across 5 years, with a median of 6226093.99 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations slumped 172854.78% in 2023, then jumped 273.1% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 12759213550.4 in 2022, then sank by 194.61% to 12070969838.86 in 2023, then slumped by 33.4% to 16102664085.05 in 2024, then jumped by 263.5% to 26328336215.46 in 2025, then tumbled by 99.93% to 18209777.84 in 2026.
  • The last three Income from Continuing Operations figures came in at 18209777.84 (Q1 2026), 26328336215.46 (Q4 2025), and 27905345.03 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -37.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -17.00 Mn
10 Nyxoah 0.69 0.69 4.26 Mn 18.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.21 Mn
Dec 31, 2025 26.33 Bn
Sep 30, 2025 -27.91 Mn
Jun 30, 2025 -23.01 Mn
Mar 31, 2025 23.41 Mn
Dec 31, 2024 -16.10 Bn
Sep 30, 2024 18.54 Mn
Jun 30, 2024 -13.66 Mn
Mar 31, 2024 12.81 Mn
Dec 31, 2023 -12.07 Bn
Sep 30, 2023 -10.71 Mn
Jun 30, 2023 -12.92 Mn
Mar 31, 2023 -12.59 Bn
Dec 31, 2022 12.76 Bn
Sep 30, 2022 -6.23 Mn
Jun 30, 2022 -5.21 Mn
Mar 31, 2022 7.29 Mn
Dec 31, 2021 4.04 Bn
Sep 30, 2021 -10.17 Mn
Jun 30, 2021 8.24 Mn